Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ariyoshi

Showing results (151-160 of 211) with videos related to

Pageof 22
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1993
[Phase I study of 5-fluorouracil and l-leucovorin]T Sasaki, K Ota, A Wakui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis]Y Akasaka, T Taguchi, K Ota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Investigation of anti-emetic effect of ondansetron tablet in multiple doses on nausea and emesis associated with cisplatin]M Suminaga, H Furue, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study]M Ikeda, T Taguchi, K Ota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1992
[Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)]K Ota, A Wakui, H Majima, et al.
The Journal of Urology|February 1, 1988
Antitumor effects of human lymphoblastoid interferon on advanced renal cell carcinomaT Fujita, H Asano, Y Naide, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1994
[Phase I clinical study of 21-consecutive-day oral administration of etoposide]K Noda, M Fukuoka, H Komatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1989
[Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for 2----6 sialyl Lewis a antigen--1. Evaluation of assay conditions and normal values]H Imura, T Takahashi, T Matsuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1992
[A phase I study on a weekly schedule of DWA2114R]H Niitani, M Fukuoka, M Furusawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1989
[Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for 2----6 sialyl Lewis a antigen--2. Evaluation of clinical significance]H Imura, T Takahashi, T Matsuda, et al.
Pageof 22

Showing results (151-160 of 211) with videos related to

Sort By:
Pageof 22
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1993
[Phase I study of 5-fluorouracil and l-leucovorin]T Sasaki, K Ota, A Wakui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis]Y Akasaka, T Taguchi, K Ota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Investigation of anti-emetic effect of ondansetron tablet in multiple doses on nausea and emesis associated with cisplatin]M Suminaga, H Furue, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study]M Ikeda, T Taguchi, K Ota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1992
[Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)]K Ota, A Wakui, H Majima, et al.
The Journal of Urology|February 1, 1988
Antitumor effects of human lymphoblastoid interferon on advanced renal cell carcinomaT Fujita, H Asano, Y Naide, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1994
[Phase I clinical study of 21-consecutive-day oral administration of etoposide]K Noda, M Fukuoka, H Komatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1989
[Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for 2----6 sialyl Lewis a antigen--1. Evaluation of assay conditions and normal values]H Imura, T Takahashi, T Matsuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1992
[A phase I study on a weekly schedule of DWA2114R]H Niitani, M Fukuoka, M Furusawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1989
[Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for 2----6 sialyl Lewis a antigen--2. Evaluation of clinical significance]H Imura, T Takahashi, T Matsuda, et al.
Pageof 22